Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

NCT00197275 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus
Hepatitis B
Haemophilus Influenzae Type b
Whole Cell Pertussis
Diphtheria

Interventions

BIOLOGICAL: Hib-MenAC mixed with Tritanrix™-HepB

Sponsor

GlaxoSmithKline